⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

WAT

Waters Corporation

Healthcare · Diagnostics & Research

404.81USD

+1.9000 (+0.47%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$4▼$4.02145
Next quarter$4.67▲$4.66711
Current year$14.58▲$14.51212
Next year$16.55▲$16.471310

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$3.01$3.05+0.04 (+1.4%)
2026-03-31$2.31$2.7+0.39 (+17.0%)
2025-12-31$4.51$4.53+0.02 (+0.5%)
2025-09-30$3.22$3.4+0.18 (+5.5%)

Wall Street coverage

265 ratings from 37 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
UBSUpgraded from NeutralBuy$375 $490Sep 9, 2026
Piper SandlerUpgraded from NeutralOverweight$400 $480Aug 27, 2026
CitigroupMaintainedBuy$425 $470Aug 10, 2026
TD CowenUpgraded from HoldBuy$408 $475Aug 5, 2026
RBC CapitalMaintainedOutperform$435 $475Aug 5, 2026
Evercore ISI GroupMaintainedOutperform$410 $420Aug 5, 2026
Wells FargoMaintainedEqual-Weight$370 $400Aug 5, 2026
BarclaysMaintainedOverweight$425 $460Aug 5, 2026
Goldman SachsMaintainedBuy$380 $425Jul 14, 2026
Morgan StanleyMaintainedEqual-Weight$350 $390Jul 9, 2026
RBC CapitalInitiatedOutperform$435Jul 9, 2026
GuggenheimReiteratedBuy$440Jul 8, 2026
Evercore ISI GroupMaintainedOutperform$380 $410Jul 6, 2026
Piper SandlerInitiatedNeutral$400Jun 11, 2026
HSBCMaintainedBuy$415 $435Jun 3, 2026
B of A SecuritiesMaintainedNeutral$370 $400Jun 2, 2026
Wells FargoMaintainedEqual-Weight$355 $370May 14, 2026
BarclaysMaintainedOverweight$400 $425May 7, 2026
UBSMaintainedNeutral$330 $375May 6, 2026
JP MorganMaintainedNeutral$330 $345May 6, 2026
TD CowenMaintainedHold$345 $385May 6, 2026
UBSMaintainedNeutral$370 $330Apr 13, 2026
Deutsche BankMaintainedHold$370 $330Mar 25, 2026
Morgan StanleyMaintainedEqual-Weight$423 $350Feb 23, 2026
Wells FargoMaintainedEqual-Weight$415 $355Feb 11, 2026

Insider transactions

60 filings from 14 insiders · 7 buy / 1 sell over 6m

Officers and directors of WAT, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
KUEBLER CHRISTOPHER ADirectorExercise3.6k$136.43$495kAug 6, 2026
KUEBLER CHRISTOPHER ADirectorSell3.6k$397.94$1.44MAug 6, 2026
JIANG WEIDirectorGrant67——Jun 30, 2026
KNIGHT HEATHERDirectorGrant63——Jun 30, 2026
JIANG WEIDirectorGrant64——Mar 31, 2026
KNIGHT HEATHERDirectorGrant68——Mar 31, 2026
JIANG WEIDirectorBuy500$289.46$145kMar 16, 2026
FEARON RICHARD HDirectorBuy1.0k$306.34$306kMar 6, 2026
FEARON RICHARD HDirectorGrant23——Feb 25, 2026
JIANG WEIDirectorGrant23——Feb 25, 2026
KNIGHT HEATHERDirectorGrant23——Feb 25, 2026
CARPIO ROBERT L IIIOfficerGrant997——Feb 25, 2026
CHAUBAL AMOLChief Financial OfficerGrant1.5k——Feb 25, 2026
BATRA UDITChief Executive OfficerGrant5.2k——Feb 25, 2026
HUANG PEARL S.DirectorGrant23——Feb 25, 2026
BENNETT JIANQINGOfficerGrant986——Feb 25, 2026
FRASER CLAIREDirectorGrant358——Feb 25, 2026
VERGNANO MARK PDirectorGrant23——Feb 25, 2026
BRENNAN DANIEL JDirectorGrant23——Feb 25, 2026
ORNSKOV FLEMMINGDirectorGrant336——Feb 25, 2026

Analyst Notes

Sign in to write

No analyst notes on WAT yet.

Analyst Ratings

23 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current314700Buy2.17
1 mo ago314700Buy2.17
2 mo ago313800Buy2.21
3 mo ago213900Buy2.29
Price target$440.65$349.00 – $480.00
+8.9% to target